¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"AML"¿¡ ´ëÇÑ ÀÇÇоà¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
    1. M0; Acute Undifferentiated Leukemia
    2. M1; AML without Differentiation(Maturation); Myeloblast Prominence
    3. M2; AML with Differentiation(Maturation); Myeloblast & Promyelocyte
    4. M3; Acute Promyelocyte Leukemia; Promyelocyte Predominate; DIC °¡ Àß»ý±è
    5. M4; Acute Myelomonocytic Leukemia; Myelocyte & Monocyte
    6. M5; Acute Monocytic Leukemia; Promonocyte or Undifferentiated Blast
    * M4 & M5 ; Extramedullary Involve°¡ ¸¹´Ù.
    7. M6; Acute Erythroleukemia; Erythroblast(ÁÖ) + Myeloblast(ÀϺÎ)
    8. M7; Megakaryocytic Leukemia; Pleomorphic Undifferentiated
AML acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukemia; acute myelogenous leukemia; anatomic medullary locking; angiomyolipoma; anterior mitral leaflet; automated multitest laboratory
AMLB alternate monoaural loudness balance
AMLC adherent macrophage-like cell; autologous mixed lymphocyte culture
AMLR autologous mixed lymphocyte reaction
AMLS antimouse lymphocyte serum
AMLSGA acute myeloblastic leukemia surface glycoprotein antigen
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á